Lisamed Technologies Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 16-11-2024
- Paid Up Capital ₹ 0.10 M
as on 16-11-2024
- Company Age 15 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 7.53 M
as on 16-11-2024
- Revenue 371.27%
(FY 2023)
- Profit 287.45%
(FY 2023)
- Ebitda 510.07%
(FY 2023)
- Net Worth 72.83%
(FY 2023)
- Total Assets 476.62%
(FY 2023)
About Lisamed Technologies
The Company is engaged in the Machinery And Equipment Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹7.53 M.
Virendra Tipnis and Suraj Tipnis serve as directors at the Company.
- CIN/LLPIN
U33111MH2009PTC196398
- Company No.
196398
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Oct 2009
- Date of AGM
23 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Thane, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Lisamed Technologies Private Limited offer?
Lisamed Technologies Private Limited offers a wide range of products and services, including Autoclaves, Sterilizers & Incubators, UV Sterilizer and Lamps, Measuring Equipments & Instruments, Moisture Meter.
Who are the key members and board of directors at Lisamed Technologies?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Suraj Tipnis  | Director | 15-Jun-2021 | Current |
| Virendra Tipnis | Director | 12-Oct-2009 | Current |
Financial Performance of Lisamed Technologies.
Lisamed Technologies Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 371.27% increase. The company also saw a substantial improvement in profitability, with a 287.45% increase in profit. The company's net worth Soared by an impressive increase of 72.83%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Lisamed Technologies?
In 2023, Lisamed Technologies had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Lisaline Lifescience Technologies Private LimitedActive 21 years 3 monthsVirendra Tipnis is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Yes Bank Limited Creation Date: 02 Jun 2017 | ₹7.53 M | Open |
How Many Employees Work at Lisamed Technologies?
Lisamed Technologies has a workforce of 5 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Lisamed Technologies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Lisamed Technologies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
